健信超导IPO：许建益一家三口控制六成表决权，妹夫赵吉明持股8.7%

Core Viewpoint - Ningbo Jianxin Superconducting Technology Co., Ltd. has received acceptance for its IPO application on the Sci-Tech Innovation Board, with Guangfa Securities as the sponsor [3] Company Overview - Jianxin Superconducting primarily engages in the research, production, and sales of core components for medical magnetic resonance imaging (MRI) equipment, including superconducting magnets, permanent magnets, and gradient coils, which account for approximately 50% of the cost of MRI equipment [3] - The company ranks fifth globally and second among domestic companies in terms of market share for superconducting magnets used in MRI equipment, making it the largest independent supplier of superconducting magnets worldwide [3] Financial Performance - Total assets as of December 31, 2024, are projected to be 671.28 million yuan, an increase from 643.48 million yuan in 2023 and 527.12 million yuan in 2022 [4] - The company's net profit is expected to rise to 55.78 million yuan in 2024, up from 48.73 million yuan in 2023 and 34.63 million yuan in 2022, indicating profit growth without revenue increase in 2024 [4] - The operating income for the years 2022 to 2024 is reported as 359.3 million yuan, 450.64 million yuan, and 424.5 million yuan respectively [4] Shareholding Structure - Xu Jianyi holds 41.51% of the company's shares, making him the controlling shareholder, while his family members Xu Hui and Xu Dianbo hold 4.36% each, collectively controlling 59.92% of the voting rights [6][7] - The family members have signed a concerted action agreement, indicating a unified decision-making process among them [7] Leadership Background - Xu Jianyi, born in September 1953, has extensive experience in the magnetic resonance industry since the late 1980s and has held various leadership positions in related companies [8]